Global Electrosurgical Devices And Equipment Market

Robotic surgery is a form of minimally invasive surgery in which doctors insert a succession of extremely small incisions and tiny surgical equipment into a patient's body. Robotic surgery is the process of performing a surgery using tools that are attached to a robotic arm. It is used to perform surgery with high precision. The robotic surgery services are used in various applications such as general surgery, urological surgery, gynecological surgery, orthopedic surgery, neurosurgery, and others. General surgery is the branch of surgery that deals with the most common surgical procedures. The abdomen, breasts, head and neck, blood arteries, and digestive tract are all treated by general surgeons. They also oversee the treatment of patients who have been wounded, or who have abnormalities or other medical issues that necessitate surgery. The different sectors include hospitals, ambulatory surgery centres (ASCs) and involves various components such as systems, accessories, services. The robotic surgery services market research report is one of a series of new reports from The Business Research Company that provides robotic surgery services market statistics, including robotic surgery services industry global market size, regional shares, competitors with a robotic surgery services market share, detailed robotic surgery services market segments, market trends and opportunities, and any further data you may need to thrive in the robotic surgery services industry. This robotic surgery services market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry. The global robotic surgery services market size will grow from $0.86 billion in 2022 to $1.01 billion in 2023 at a compound annual growth rate (CAGR) of 17.8%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The global robotic surgery services market size is expected to grow to $1.8 billion in 2027 at a CAGR of 15.4%. Increase in purchasing power of hospitals and ambulatory care services has helped in the growth of the robotic surgery service market. Hospitals and ambulatory care services are interested in buying latest technologies to provide advanced care to the patients as well as to achieve an edge over their competitors. According to the fourth quarter and full year financial results 2021 of Intuitive Surgical, the robotic surgical giant, the company shipped 385 da Vinci Surgical Systems in fourth quarter, up 18% from the third quarter's 326 units shipped. In 2021, the company shipped 1,347 da Vinci Surgical Systems, a 44% increase from the 936 systems shipped in 2020.Therefore, the purchasing power of hospital and ambulatory care services coupled with the increase in the geriatric population and prevalence of chronic illness have contributed to the growth of robotic surgery services market. Safety concerns regarding the use of robotic surgery services are likely to cause a hindrance to the robotic surgery services market. According to a study on adverse events with robotic-assisted arthroplasty by American Academy of Orthopedic Surgeons, the unexpected robotic arm movement during bone cuts during TKA was the most common adverse event (AE), accounting for 28.9% of all reported AEs, followed by erroneous bone cuts (12.7%) and the robotic component leaking fluid or having residual contaminants (12.3 percent). Accurate bone resections accounted for more than a quarter of all adverse events associated with robotic-assisted PKA. A registration checkpoint being left in the patient accounted for 43.2 percent of all reported adverse events (AEs) in THA patients. Therefore, the safety issues pertaining to robotic surgeries leading to product recalls is expected to hinder the growth of the robotic surgery services market. The image guide navigation system combined with the robotic surgery system offers more possibility to visualize and perform minimally invasive surgery in areas that were earlier difficult, especially the orthopedic surgeries and neurosurgeries. The Mazor X Stealth system by Medtronic, and the NuVasive's Pulse and Excelsius GPS by Globus Medical, among others use image-guided navigation systems to perform spine surgeries, and orthopaedic implant surgeries such as total, partial knee, and hip replacements as they provide the surgeon with 3D experience. The image-guided navigation reduces the radiation effects and patients do not require to take an X-ray after the procedure. These factors state that the image-guided navigation system is expected to be a trend in robotic surgery services. In February 2022, Medtronic PLC., a US-based medical device company, acquired Digital Surgery for an undisclosed amount. Through this acquisition, Digital Surgery will enhance Medtronic's robotic-assisted surgery platform and expand Medtronic's wider range of products. Digital Surgery is a UK-based is a privately held pioneer in digital education and training, data and analytics, and surgical artificial intelligence (AI). Major players in the robotic surgery services market are Intuitive Surgical Inc., Stryker Corporation, Medrobotics Corporation, Johnson & Johnson, Globus medicals, NuVasive, Smith & Nephew PLC., Titan Medical Inc., TransEnterix Inc. and University of Pittsburgh Medical Centre. North America was the largest region in the robotic surgery services market in 2022. Western Europe was the second largest region in the global robotic surgery services market.The regions covered in the global robotic surgery services market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa. The countries covered in the robotic surgery services market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA. The robotic surgery services market includes revenues earned by entities by providing robotic gynaecological services, robotic prostate surgery services, robotic kidney surgery services, and robotic colorectal surgery services. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified). The revenues for a specified geography are consumption values – that is, they are revenues generated by organizations in the specified geography within the specified market, irrespective of where they are produced.It does not include revenues from resales either further along the supply chain or as part of other products. The global robotic surgery services market is segmented - 1) By Component: Systems, Accessories, Services 2) By Application: General Surgery, Urological Surgery, Gynecological Surgery, Orthopedic Surgery, Neurosurgery, Other Applications 3) By End-User: Hospitals, Ambulatory Surgery Centers (ASCs)

Robotic surgery devices help doctors perform complex minimally invasive operations with precision and flexibility. The main product and services in the robotic surgery devices market are robotic systems, instruments and accessories, and services. The services are provided by the robots and are also called robot-assisted surgery services. The various surgery types are urological surgery, gynecological surgery, orthopedic surgery, neurosurgery, and others. These are used in hospitals and ambulatory surgery centres. The robotic surgery devices market research report is one of a series of new reports from The Business Research Company that provides robotic surgery devices market statistics, including robotic surgery devices industry global market size, regional shares, competitors with a robotic surgery devices market share, detailed robotic surgery devices market segments, market trends and opportunities, and any further data you may need to thrive in the robotic surgery devices industry. This robotic surgery devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry. The global robotic surgery devices market size will grow from $6 billion in 2022 to $6.84 billion in 2023 at a compound annual growth rate (CAGR) of 14.1%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The global robotic surgery devices market size is expected to grow from $11.65 billion in 2027 at a CAGR of 14.2%. The rise in demand for minimally invasive technology is driving the robotic surgery devices market. Minimally Invasive (MI) surgery devices are equipped with imaging and catheter technologies that can be easily inserted into any part of the body. Robotic surgery procedures are usually associated with minimally invasive surgeries. These technologies are mainly used for heart, laparoscopy, orthopedic, gynecological, and urological surgeries. Robotic surgeries were introduced to reduce patient hospital length of stay (LOS), pain, complications, return to work time, and reoperations. According to the Intuitive Surgical company report, there is a 24% growth year on year for instruments and accessories. For robotic systems, the company has gained 16% growth and the overall robotic surgery devices market is growing at a rate of 13% -16%. The Intuitive Surgical company estimates that more than 1.2 million surgical procedures were done by using their robotic systems. Consumer preferences are changing, and hospitals are adopting robotic surgery devices to create more value and cost-effective surgical procedures. Expensive robotic surgery is hampering the robotic surgery devices market. Robotic surgery is comparatively more expensive than other traditional ways of surgeries as it is associated with a lot of complications, requires highly trained senior doctors to operate robotic systems/instruments, complex technical operations, and maintenance. A single robotic system costs around $2 million and the surgery costs about a range of $3000 - $6000. The annual maintenance cost of robotic surgery devices usually costs between $100,000 - $170,000. The largest robotic surgery device manufacturer Intuitive Surgical supplies the single-use or disposable surgical tools used for robotic arms for surgeries. This is one of the reasons that robotic surgeries are more costly. The huge cost associated with robotic surgeries is therefore hindering the market growth. The advances in surgical products and technologies in the health care industry are creating more opportunities in the robotic surgery devices market. Increasing investments in R&D is helping investors to create value for the customers by producing medical-surgical products like robotic surgery devices by using the latest technologies. With the use of robotic systems that are equipped with optical imaging, surgical tools, instruments, and accessories, the surgeries are made easier. Some of the surgical advances that are creating more value and opportunity in the healthcare industry include 3-D high definition endoscope (Multi-Angle Rear-Viewing Endoscopic tool) devices for Brain surgery, Smart surgical glasses (equipped with a video camera and Head-mounted monitor) that act like computers, and can use for live observation of surgeries, surgical robots with artificial intelligence that acts as doctors, and humanoid robots which are used for highly critical surgeries in eye and brain. The other advanced surgical tool is remote robotics, which is used to assist with surgery from any remote location. Therefore, robotic surgery devices are playing an important role in the healthcare industry with their technological advancements and innovations. In February 2020, Medtronic PLC., a US-based medical device manufacturer, acquired Digital Surgery for an undisclosed amount. The acquisition would help Medtronic in clinical decision support and reduce its cost. It will also help them to grow in the robotic surgery vertical. Digital Surgery is a UK-based manufacturer of digital surgical tools. Major players in the robotic surgery devices market are Intuitive Surgical, Stryker, Medtronic, Smith & Nephew, TransEnterix, Mazor Robotics, Medrobotics, Accuray, THINK Surgical, and TINAVI Medical Technology Co. Ltd. North America was the largest region in the robotic surgery devices market in 2022. Western Europe was the second largest market in global robotic surgery devices market. The regions covered in the global robotic surgery devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa. The countries covered in the robotic surgery devices market are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, the UK, and USA. Robotic surgery equipment market consist of sales of robotic systems, instruments and accessories that are used for robotic surgeries. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products. The global robotic surgery devices market is segmented - 1) By Product and Service: Robotic systems, Instruments & Accessories, Services 2) By Surgery Type: Urological surgery, Gynecological surgery, Orthopedic surgery, Neurosurgery, Other Surgery Types 3) By End User: Hospitals, Ambulatory Surgery Centers

A medical robot is an expert service robot that refers to a type of multipurpose device used in and outside of hospitals to raise the standard of care provided to patients and it is employed in complicated surgical procedures, limb replacement, stroke patient rehabilitation, and other health-related duties. The medical robot is used in the medical sciences to help with surgeries, improve patient care and worker safety, and streamline clinical workflow and hospital logistics. The main types of medical robots are hospital and pharmacy robotic systems, surgical robotic systems, noninvasive radiosurgery robotic systems, rehabilitation robotic systems, and others. Hospital and pharmacy robotic systems refer to the robots used to distribute medicine to patients and to be involved in the automation of common tasks and processes performed in a pharmacy or other healthcare settings. The solutions include on-premises and cloud and are applied in cardiology, laparoscopy, pharmacy, neurosurgery, orthopedic surgery, and others used by various end-users such as specialty centers, hospitals and clinics, rehabilitation centers, and others. The medical robots market research report is one of a series of new reports from The Business Research Company that provides medical robots market statistics, including medical robots industry global market size, regional shares, competitors with a medical robots market share, detailed medical robots market segments, market trends and opportunities, and any further data you may need to thrive in the medical robots industry. This medical robotics market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry. The global medical robots market size grew from $11.17 billion in 2022 to $13.25 billion in 2023 at a compound annual growth rate (CAGR) of 18.6%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services, causing inflation across goods and services and affecting many markets across the globe. The medical robots market size is expected to grow to $26.43 billion in 2027 at a CAGR of 18.9%. The rising demand for precise and proper laparoscopic operations is expected to propel the growth of the medical robot market going forward. The laparoscopic operation allows a surgeon to perform complex procedures within the abdomen without having to place his hands directly into the body cavity. Medical robots are more efficient at performing laparoscopic procedures. As a result, there is rising demand for precise and proper laparoscopic operations that boost market growth. For instance, in March 2022, the Cleveland Clinic, a US-based nonprofit academic medical centre, stated that over 13 million laparoscopic procedures have been performed globally every year and are projected to grow by 1% over the next five years. Therefore, the rising demand for precise and proper laparoscopic operations is driving the growth of the medical robot market. Technological advancements are a key trend gaining popularity in the medical robot market. Major companies operating in the medical robot market are focused on developing new technological solutions to strengthen their position. For instance, in April 2022, Diligent Corporation, a US-based healthcare robotics company, created Moxi, an AI-enabled robot that can handle time-consuming logistical tasks in hospitals such as setting up patient rooms and replenishing supplies. Moxi is able to deliver teleboxes, manage the "do not tube" medications, and pick up patients' personal items. Moxi’s core technical features comprise social intelligence, mobile manipulation, and human-guided learning. This launch represents another step forward for Diligent’s product portfolio. In February 2021, Ascendum Capital, a China-based company specializing in healthcare-focused investment platforms, acquired EndoWays Ltd for an undisclosed amount. This acquisition would accelerate EndoWays clinical and commercial development, especially in China, by leveraging the experience and network of Ascendum's team. EndoWays Ltd is an Israel-based robotics company. The company features a software platform called the microcatheter which is designed to allow interventional radiologists to cross tortuous anatomy, and reduce procedure time and radiation exposure to patients and the medical staff. Major players in the medical robot market are Smith and Nephew PLC, Strikers, Aethon, Intuitive Surgical Inc., Major Robotics, Intouch Technologies Inc., Renishaw PLC., MedTech SA, Ekso Bionics Holdings Inc., ReWalk Robotics , Medrobotics Corporation, McKesson Corporation, Hocoma AG, Cyberdyne Inc., and BD Rowa. North America was the largest region in the medical robot market in 2022. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the medical robot market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa. The countries covered in the medical robot market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, the UK, and the USA. The medical robot market consists of sales of radiotherapy machine robots, laboratory robots, robotic prosthetics, and social robots. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products. The global medical robots market is segmented - 1) By Type: Hospital and Pharmacy Robotic Systems, Surgical Robotic Systems, Noninvasive Radiosurgery Robotic Systems, Rehabilitation Robotic Systems, Other Types 2) By Solutions: On-Premises, Cloud 3) By Application: Cardiology, Laparoscopy, Pharmacy, Neurosurgery, Orthopedic Surgery, Other Applications 4) By End Users: Specialty Centers, Hospitals and Clinics, Rehabilitation Centers, Other End Users 

Minimally invasive surgery devices are surgical tools that require fewer incisions of a smaller size or have a quicker healing process. A minimally invasive medical device is implanted inside the patient during surgery. The main product types of minimally invasive surgery devices are handheld instruments, inflation devices, cutter instruments, guiding devices, electrosurgical devices, auxiliary devices, monitoring and visualization devices. The electrosurgical devices are used to destroy tissue, incise tissue, and control bleeding by coagulating blood. The various applications of minimal invasive surgery devices are laparoscopy, cardiovascular, cosmetic surgery, orthopedic surgery, obstetrics and gynecology, ophthalmology, neurosurgery, urology, and others that are used by end-users such as hospitals, ambulatory surgical centres (ASCS), and research institutes. The minimally invasive surgery devices market research report is one of a series of new reports from The Business Research Company that provides minimally invasive surgery devices market statistics, including minimally invasive surgery devices industry global market size, regional shares, competitors with a minimally invasive surgery devices market share, detailed minimally invasive surgery devices market segments, market trends and opportunities, and any further data you may need to thrive in the minimally invasive surgery devices industry. This minimally invasive surgery devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry. The global minimal invasive surgery devices market grew from $28.98 billion in 2022 to $31.64 billion in 2023 at a compound annual growth rate (CAGR) of 9.2%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The minimal invasive surgery devices market is expected to grow from $39.48 billion in 2027 at a CAGR of 5.7%. The increasing awareness for minimally invasive surgeries among people is driving the minimally invasive surgery devices market. The minimally invasive surgeries require less/tiny cuts in the skin as compared to traditional surgical methods and aid in lesser pain, short hospital stay, less scarring, minimized chances of bleeding and infections, and low tissue damage. According to the German Heart Surgery Report, the heart operations using ECC (extracorporeal circulation) declined due to achievement of established innovations in minimally invasive therapeutic options in heart surgeries. Furthermore, 51.1% of heart valve operations performed out of the total cardiac surgical procedures in Germany were through the single-valve procedure, out of which 38.5% of them were through minimal invasive heart surgeries. Thus, the growing demand for minimally invasive surgery (MIS) will increase the demand for the minimally invasive surgical devices market. The rising trade barriers are expected to have a negative impact on the minimally invasive surgery devices market growth. Many countries placed trade restrictions, especially on imports, to boost local production. For instance, Brexit is likely to lead to more trade restrictions between the UK and other countries in Europe. The US is also implementing several trade restrictions, especially with China, to boost its local production. For instance, the US government imposed an additional 25% tariff on approximately $16 billion worth of imports from China, including minimally invasive surgical devices and equipment and supplies. These trade restrictions are likely to limit the growth of demand going forward by leading to raised prices. Technologically advanced minimally invasive surgery (MIS) devices with improvements in image guidance, fiber-optics, mini dental implants, and robotic control systems are increasingly opted by patients to treat medical conditions such as aneurysms, cardiac procedures, dental and spinal procedures. Less-invasive surgical procedures with enhanced capabilities in the areas of imaging, micromachining, robotic equipment and components, software systems, and others are becoming popular in the healthcare industry. For instance, video-assisted thoracoscopic surgery (VATS), is a minimally invasive surgical procedure performed to completely remove an organ of the human body to treat traumatic injury, infection, or cancer in the lungs. VATS is performed using a video camera where a small tube called a thoracoscope to which the camera is connected, is inserted through a small incision between the ribs. Furthermore, imaging technology involved in MIS, virtual reality (VR) is becoming a significant area of development. Other MIS techniques are applied to perform surgeries such as single-site laparoscopic surgery, robotic surgeries, needlescopic surgery, cardiac and spinal surgeries, and others. Food and Drug Administration Act (FDA) regulates the minimally invasive surgical devices market in the United States of America. The firms manufacturing robotic minimally invasive surgical devices have to list down any possible risks to health and measures taken by them so that the device addresses health hazards if any stated by FDA. However, the FDA is concerned about the health care providers and patients for not being aware of the safety and effectiveness of these devices as they should not be used in mastectomy procedures or prevention or treatment of cancer. Major players in the minimally invasive surgery devices market are Abbott Laboratories, GE Healthcare, Medtronic PLC., Siemens Healthineers, Smith & Nephew PLC., Medtronic PLC., Stryker Corporation, Boston Scientific Corporation, Ethicon Inc., and B. Braun Melsungen AG. North America was the largest region in the minimally invasive surgery devices market in 2022. Western Europe was the second largest region in the global minimally invasive surgery devices market report. The regions covered in the global minimally invasive surgery devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa. The countries covered in the minimally invasive surgery devices market are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, and USA. The minimally invasive surgery devices market consists of sales of graspers, retractors/elevators, dilators, suturing instruments, laparoscopes, gastroscope, cystoscope, and ureteroscop. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products. The global minimal invasive surgery devices market is segmented - 1) By Product Type: Handheld Instruments, Inflation Devices, Cutter Instruments, Guiding Devices, Electrosurgical Devices, Auxiliary Devices, Monitoring & Visualization Devices 2) By Application: Laparoscopy, Cardiovascular, Cosmetic Surgery, Orthopedic Surgery, Obstetrics And Gynecology, Ophthalmology, Neurosurgery, Urology, Other Applications 3) By End Users: Hospitals, Ambulatory Surgical Centers (ASCS), Research Institutes

Medical equipment are devices that can be instrument, apparatus or machine that can be used in the prevention, diagnosis or treatment of illness or disease, or for detecting, measuring, restoring, correcting or modifying the structure or function of the body for health purpose. The main types of medical equipment are in-vitro diagnostics, dental equipment and supplies, ophthalmic devices, diagnostic imaging equipment, cardiovascular devices, hospital supplies, surgical equipment, orthopedic devices, patient monitoring devices, diabetes care devices, nephrology and urology devices, ENT devices, anesthesia and respiratory devices, neurology devices, and wound care devices. In-vitro diagnostics are tests done on samples like blood or tissue that is taken from the human body. In-vitro diagnostics will detect diseases or other conditions and are used to monitor a person’s overall health to cure, treat, or prevent diseases. The type of expenditure involved is public and private. The various product are instruments/equipment and disposables. The various end users involved are hospitals and clinics, homecare, diagnostics centres, and others. The medical equipment market research report is one of a series of new reports from The Business Research Company that provides medical equipment market statistics, including medical equipment industry global market size, regional shares, competitors with a medical equipment market share, detailed medical equipment market segments, market trends and opportunities, and any further data you may need to thrive in the medical equipment industry. This medical equipment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry. The global medical equipment market grew from $639.75 billion in 2022 to $695.05 billion in 2023 at a compound annual growth rate (CAGR) of 8.6%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The medical equipment market is expected to grow to $922.39 billion in 2027 at a CAGR of 7.3%. The rise in sedentary jobs, busy lifestyles, and changing consumer preferences are affecting the disease profile of the world population, especially non-communicable diseases such as cancer, diabetes, and cardiovascular diseases. Long working hours, less physical activity, and unhealthy eating and drinking habits are major causes of chronic diseases such as diabetes. According to the World Health Organization, chronic disease prevalence is expected to rise by 57% globally, by the year 2020. This is increasing the demand for medical devices used in the diagnosis, prognosis, and treatment of several diseases, thereby driving the demand for medical equipment. These factors are expected to increase the patient pool globally, thereby driving the market during the forecast period. Regulatory changes are likely to lead to increased costs relating to new product development and service offerings to clients. These changes are related to customer data protection such as the European Union's General Data Protection Regulation (GDPR), changes to equipment approval procedures, and other regulatory changes. For instance, according to cookieyed data 2021, in the US, PwC reported that 68% of 200 businesses surveyed intended to spend between $1 million and $10 million to comply with GDPR regulations. The GDPR regulation is an EU law on data protection and privacy of individuals residing in the European Union and the European Economic Area (EEA). It also regulates the export of personal data outside the EU and EEA areas. Additionally, the FDA is requesting more clinical data to support claims, therefore increasing the time to process 510(k)s by over 55% over the last decade. The potential loss of revenue due to delays in product release and additional costs incurred due to stringent approval processes puts a strain on investments relating to new product development, thereby affecting the growth of the medical equipment market. Device performance and patient data are available to healthcare service providers and are helping them to improve patient monitoring and overall care quality. Some companies are integrating medical device data with EMR (Electronic Medical Records) to improve transparency and collaboration. As consumer wearables are becoming more common, patient data volumes are increasing and companies are investing in deploying data management, warehousing, and security technologies. For example, Medtronic launched a tool to augment their cardiac devices to securely transfer device data to doctors and allow them to monitor the critical health indicators of their patients. Major companies in the medical equipment market include Medtronic Inc., Abbott Laboratories, Johnson & Johnson, Cardinal Health, Inc., Becton Dickinson, Siemens AG, STRYKER CORPORATION, Koninklijke Philips N.V., F. Hoffmann-La Roche Ltd., and Boston Scientific Corporation. North America was the largest region in the global medical equipment market in 2022. Asia-Pacific was the second largest region in the global medical equipment market. The regions covered in the medical equipment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa. The countries covered in the medical equipment market are Argentina, Australia, Austria, Belgium, Brazil, Canada, Chile, China, Colombia, Czech Republic, Denmark, Egypt, Finland, France, Germany, Hong Kong, India, Indonesia, Ireland, Israel, Italy, Japan, Malaysia, Mexico, Netherlands, New Zealand, Nigeria, Norway, Peru, Philippines, Poland, Portugal, Romania, Russia, Saudi Arabia, Singapore, South Africa., South Korea, Spain, Sweden, Switzerland, Thailand, Turkey, UAE, UK, USA, Venezuela, and Vietnam. The medical equipment market consists of sales of devices used in the diagnosis, treatment and monitoring of medical conditions. The market includes diagnostic devices, imaging devices, surgical devices and patient monitoring devices. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products. The global medical equipment market is segmented - 1) By Type: In-Vitro Diagnostics, Dental Equipment And Supplies, Ophthalmic Devices, Diagnostic Imaging Equipment, Cardiovascular Devices, Hospital Supplies, Surgical Equipment, Orthopedic Devices, Patient Monitoring Devices, Diabetes Care Devices, Nephrology And Urology Devices, ENT Devices, Anesthesia And Respiratory Devices, Neurology Devices, Wound Care Devices 2) By Type of Expenditure: Public, Private 3) By Product: Instruments/Equipment, Disposables 4) By End User: Hospitals And Clinics, Homecare, Diagnostics Centers, Other End Users Subsegments Covered: Point-of-Care Diagnostics Devices And Equipment, Immunochemistry Diagnostic Devices And Equipment, Clinical Chemistry Diagnostics Devices And Equipment, Molecular Diagnostics Devices And Equipment, Microbiology Diagnostic Devices And Equipment, Hemostasis Diagnostic Devices And Equipment, Hematology Diagnostic Devices And Equipment, Immunohematology Diagnostic Devices And Equipment, Therapeutic Dental Equipment, General Dental Devices And Equipment, Dental Diagnostic Imaging Devices And Equipment, Dental Surgical Devices And Equipment, Vision Care Devices And Equipment, Cataract Surgery Devices And Equipment, Refractive Surgery Devices And Equipment, Diagnostic And Monitoring Ophthalmic Devices And Equipment, X-Ray Systems Devices And Equipment, Ultrasound Systems Devices And Equipment, Computed Tomography (CT) Scanners Devices And Equipment, Magnetic Resonance Imaging Systems Devices And Equipment, Cardiovascular Monitoring And Diagnostic Devices And Equipment, Nuclear Imaging Devices And Equipment, Cardiovascular Surgery Devices And Equipment, Cardiac Rhythm Management (CRM) Devices And Equipment, Interventional Cardiology Devices And Equipment, Defibrillator Devices And Equipment, Peripheral Vascular Devices And Equipment, Prosthetic Heart Valve Devices And Equipment, Electrophysiology Devices And Equipment, Cardiac Assist Devices And Equipment, Disposable Hospital Supplies, Sterilization Equipment And Disinfectants, Mobility Aids And Transportation Equipment, Operating Room Equipment, Surgical Sutures And Staples, Handheld Surgical Devices And Equipment, Electrosurgical Devices And Equipment, Joint Reconstruction Devices And Equipment, Spinal Surgery Devices And Equipment, Trauma Fixation Devices And Equipment, Orthobiologics Devices And Equipment, Arthroscopy Devices And Equipment, Orthopedic Braces And Support Devices And Equipment, Craniomaxillofacial (CMF) Devices And Equipment, Orthopedic Prosthetics, Orthopedic Accessories,, Fetal And Neonatal Monitoring Devices, Weight Monitoring And Body Temperature Monitoring Devices And Equipment, Vital Parameter Monitoring Devices And Equipment, Remote Patient Monitoring Devices And Equipment, Blood Glucose Test Strips, Insulin Pens, Syringes, Pumps And Injectors, Lancing Devices And Equipment, Continuous Glucose Monitoring Devices And Equipment, Blood Glucose Meters, Dialysis Devices And Equipment, Urinary Stone Treatment Devices And Equipment, Urinary Incontinence & Pelvic Organ Prolapse Devices And Equipment, Benign Prostatic Hyperplasia (BPH) Treatment Devices And Equipment, Endoscopy Devices And Equipment, Hearing Aid Devices And Equipment, Hearing Diagnostic Devices And Equipment, ENT Surgical Devices And Equipment, Hearing Implants, Voice Prosthesis Devices And Equipment, Nasal Splints, Respiratory Devices And Equipment (Therapeutic And Diagnostic), Anesthesia Machines, Anesthesia Disposables, Respiratory Disposables, Cerebrospinal Fluid Management (CSF) Devices And Equipment, Interventional Neurology Devices And Equipment, Neurosurgery Devices And Equipment, Neurostimulation Devices, Traditional Adhesive Dressings, Negative-pressure Wound Therapy (NPWT), Traditional Gauze Dressings, Advanced Wound Care Devices

Refractive surgery devices and equipment are used in refractive error surgeries, a procedure for correcting or improving vision affected by a refractive error such as nearsightedness (myopia), farsightedness (hyperopia), presbyopia, or astigmatism. The main product types of refractive surgery devices (or) equipment are microkeratome, excimer lasers, femtosecond lasers, and YAG lasers. The excimer laser is a laser that emits concentrated light in the ultraviolet (UV) region of the spectrum. The various applications involved are astigmatism, near-sightedness, and farsightedness that are used by end-users such as hospitals, ambulatory surgical centres, and ophthalmology clinics. The refractive surgery devices (or) equipment market research report is one of a series of new reports from The Business Research Company that provides refractive surgery devices (or) equipment market statistics, including refractive surgery devices (or) equipment industry global market size, regional shares, competitors with a refractive surgery devices (or) equipment market share, detailed refractive surgery devices (or) equipment market segments, market trends and opportunities, and any further data you may need to thrive in the refractive surgery devices (or) equipment industry. This refractive surgery devices (or) equipment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry. The global refractive surgery devices and equipment market size will grow from $0.15 billion in 2022 to $0.17 billion in 2023 at a compound annual growth rate (CAGR) of 10.6%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The refractive surgery devices and equipment market size is expected to grow to $0.24 billion in 2027 at a CAGR of 9.5%. A significant driving factor for the growth of the Refractive surgery devices and equipment market is an increase in the geriatric population worldwide with eye disorders. Age-related macular degeneration is the major cause of loss of vision over the age of 65 years. There are many elderly people with refractive errors who require immediate surgical care to cure visual impairment. The rising elderly population throughout the year increases the demand for refractive surgeries. For example, the elderly population in USA is steadily growing and by 2030, 70 million Americans will be over 65 years of age. Approximately one in three older people have optic disorders which are boosting the refractive surgery devices and equipment market. The Refractive surgery devices and equipment market is being restrained due to the lack of use of surgical equipment to treat refractive errors, in developing nations. Also, backwardness, poverty, and lack of knowledge make the patients unaware of the procedures of the surgery. For example, according to WHO the visual impairment in Rwanda, an African country is 5.3% and more than 80% of the eye cases were refractive errors which were considered treatable but due to lack of ophthalmic surgical devices there is no cure. People in developing countries witness more cases related to blindness than in developed countries. The focus areas for many companies in the refractive surgery devices and equipment market has shifted towards increasing technological advancements in the field of refractive surgery. Advanced technologies used for correcting refractive errors expand the scale of the treatment, reduce the time and labor costs. The new corneal refractive surgical techniques such as femtosecond corneal surgery technique, pseudophakic intraocular lenses, intraocular rings and segments, and corneal stiffening techniques such as collagen crosslinking may impact the market significantly. For instance, the intrastromal femtosecond laser-assisted lenticular corneal excision (Flex-Smile) technique is very effective for myopic cases of up to 10 diopters with astigmatism up to 3. Also, the advanced femtosecond laser surgical instruments have many unique features such as complete surgical control down to the micron in terms of diameter, depth and edge angle, fast flap creation. In the USA, FDA (Foods and Drugs Administration) regulates the sale of medical devices and monitors the safety of all regulated medical devices. FDA regulates the sales of medical devices for refractive surgery. Major players in the refractive surgery devices (or) equipment market are Alcon, J & J, Zeiss, Bausch, and Lomb (Valeant), Ziemer Ophthalmic, Nidek, STAAR, Avedro, Lensar, and iVIS Technologies. North America was the largest region in the global refractive surgery devices (or) equipment market in 2022. Asia-Pacific was the second-largest region in the refractive surgery devices (or) equipment market. The regions covered in the global refractive surgery devices (or) equipment report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa. The countries covered in the refractive surgery devices (or) equipment market are Brazil, China, France, Germany, India, Indonesia, Japan, South Korea, Russia, UK, USA, and Australia. The Refractive surgery devices and equipment market consist of sales of microkeratome, excimer lasers, femtosecond lasers, YAG lasers, and aberrometers that are used for refractive surgeries. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products. The global refractive surgery devices and equipment market is segmented - 1) By Product Type: Microkeratome, Excimer Lasers, Femtosecond Lasers, YAG Lasers 2) By End User: Hospitals, Ambulatory Surgical Centres, Opthalmology Clinics 3) By Application: Astigmatism, Near-sightedness, Farsightedness

Surgical retractors are the medical instruments that are used during a surgical procedure to keep the area of incision or surgery open. The device improves visibility and contributes to a more effective surgical procedure. The surgical retractors are used to hold an incision or wound open while a surgeon works. The main types of surgical retractors are handheld and self-retaining. The handheld is used to secure surgical incisions in an open position and pull back on ligaments, tissues, and other structures at the operative site. Handheld retractors are surgical devices that separate bodily tissues during surgery that are held by an assistant, a robot, or the surgeon during a procedure. The different designs include fixed or flat-frame retractors, angled or curved-frame retractors, and blade or elevated-tip retractors and involve various usages such as tissue handling and dissection, and fluid swabbing. The main applications include neurosurgery, wound closure, reconstructive surgery, cardiovascular, orthopedic, obstetrics and gynaecology, and others. The different end users include hospitals and surgical centers, ambulatory care centers, and others. The surgical retractors market research report is one of a series of new reports from The Business Research Company that provides surgical retractors market statistics, including surgical retractors industry global market size, regional shares, competitors with a surgical retractors market share, detailed surgical retractors market segments, market trends and opportunities, and any further data you may need to thrive in the surgical retractors industry. This anomaly detection market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry. The global surgical retractors market size grew from $2.19 billion in 2022 to $2.38 billion in 2023 at a compound annual growth rate (CAGR) of 8.6%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The surgical retractors market size is expected to grow to $3.13 billion in 2027 at a CAGR of 7.1%. An increase in number of surgical procedures is expected to propel the growth of the surgical retractors market going forward. A surgical procedure is a medical treatment that involves making an incision and using tools to stop or repair disease in a living body. A variety of medical disorders are diagnosed, investigated, or treated via surgical procedures. Surgical retractors are mostly used in open surgery, endoscopy, dermatology, ophthalmology, and dentistry, and old tissues or organs during surgeries. For instance, according to the American Society for Aesthetic Plastic Surgery, a US-based organization devoted to aesthetic plastic surgery and cosmetic medicine, in the US, surgical procedures increased by 54% in 2021. Therefore, the increasing number of surgical procedures is driving the growth of the surgical retractor market. Technological advancements are the key trends gaining popularity in the surgical retractors market. Major companies operating in the surgical retractors market are introducing new technologies to sustain their position in the market. For instance, in August 2021, Advanced Surgical Retractor Systems Inc., a US-based medical equipment company launched exploratory laparotomy with the new TITAN Cestero surgical retractor (CSR), an advancement in surgical retractor technology. The TITAN CSR combines multiple retractors in one novel device and is designed to integrate with Bookwalter blades. It provides optimal exposure to deep and retroperitoneal structures boasting a 50x faster setup speed. In April 2022, Carl Zeiss Meditec AG, a Germany-based medical technology company acquired Kogent Surgical LLC and Katalyst Surgical LLC for an undisclosed amount. This acquisition would help Carl Zeiss Meditec AG to its businesses grow, enhance its surgical solution portfolio, and bring in more recurring income. Kogent Surgical LLC is a US-based renowned innovator in the medical device industry with a focus on microsurgical instruments, surgical site illumination, and electrosurgery. Katalyst Surgical LLC is a US-based company specializing in titanium ophthalmic surgical instruments. Major players in the surgical retractors market are B. Braun, Becton, Dickinson and Company, Henry Schein Inc., Integra Lifesciences Holdings Corporation, Johnson & Johnson Private Limited, Medline Industries Inc., Medtronic PLC., Teleflex Incorporated, Terumo Corporation, The Cooper Companies Inc., Applied Medical Resources Corporation, Arthrex Inc., Stryker Corporation, Bausch Health Companies Inc., Enovis Corporation, and Globus Medical Inc. North America was the largest region in the surgical retractors market in 2022. Europe was the second-largest region in the surgical retractors market. The regions covered in the surgical retractors market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa. The countries covered in the surgical retractors market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA. The surgical retractors market consists of sales of distractors equipment’s, positioners and stereotactic devices, mechanical cutters, and backbiting forcep scissors. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products. The global surgical retractors market is segmented - 1) By Type: Handheld, Self-retaining 2) By Design: Fixed or Flat-Frame Retractors, Angled or Curved-Frame Retractors, Blade or Elevated-Tip Retractors 3) By Usage: Tissue Handling And Dissection, Fluid Swabbing 4) By Application: Neurosurgery, Wound Closure, Reconstructive Surgery, Cardiovascular, Orthopedic, Obstetrics And Gynecology, Others Applications 5) By End User: Hospitals And Surgical Centers, Ambulatory Care Centers, Other End Users

Hand-held surgical instruments are usually built of premium stainless steel and come in a wide range of sizes, styles, and shapes appropriate for various surgical procedures. Hand-held surgical instruments are used in the surgical procedures and operated on while being held in hand. A wide variety of hand-held surgical instruments are used in numerous surgical operations, including scalpels, forceps, scissors, and retractors. The main product types of hand-held surgical instruments are forceps, retractors, dilators, graspers, scalpels, and others. Forceps are used for securely grabbing, pulling, or holding items, especially during delicate operations. A forceps is a two-bladed tool with a handle that can be used for various tasks, including managing sterile dressings, squeezing or gripping tissues, and others. Neurosurgery, cardiovascular, orthopedic, plastic and reconstructive surgery, obstetrics and gynecology are the applications of hand-held surgical instruments. These instruments are used by hospitals, clinics, and ambulatory surgical centers. The hand-held surgical instruments market research report is one of a series of new reports from The Business Research Company that provides hand-held surgical instruments market statistics, including hand-held surgical instruments industry global market size, regional shares, competitors with a hand-held surgical instruments market share, detailed hand-held surgical instruments market segments, market trends and opportunities, and any further data you may need to thrive in the hand-held surgical instruments industry. This hand-held surgical instruments market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry. The global hand-held surgical instruments market size grew from $5.99 billion in 2022 to $6.48 billion in 2023 at a compound annual growth rate (CAGR) of 8.1%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The hand-held surgical instruments market size is expected to grow to $8.63 billion in 2027 at a CAGR of 7.4%. An increase in the geriatric population is driving the hand-held surgical instruments market. The geriatric population consists of adults 65 years of age and older. People at this age are more prone to fall ill and catch a severe disease that needs proper treatment and surgical intervention. Surgical instruments are used in surgeries and carrying out treatment for various diseases. For instance, according to a report by United Nations on World Population Ageing 2020, a US-based intergovernmental organization, the world population aging in 2020 was about 727 million people aged over 65 years and expected to reach 1.5 billion in 2050. Throughout the world, there is an increased population of over-aged 65-year-olds, which stood at 9.3% in 2020 and is expected to reach 16.0% by 2050. Therefore, the increasing geriatric population will propel the hand-held surgical instruments market. Technological advancement is a key trend gaining popularity in the hand-held surgical instruments market. Major players in the hand-held surgical instruments market are adopting smart surgical instruments to treat various diseases. Smart surgical instruments are user-friendly, advanced tools that save time and money. For instance, in November 2021, OrthAlign, a US-based medical equipment manufacturer, introduced a new, hand-held smart surgical instrument called Lantern for full and partial knee replacements. The solution offers streamlined workflows to reduce operating room wait times and support numerous operating rooms at once without requiring the investment in hardware or pre-operative imaging required by various computer-assisted surgical systems. In October 2020, Katena Products Inc., a surgical equipment provider that includes cannulas, forceps, needle holders, phaco choppers, scissors, spatulas, and many more, acquired Micro Select for an undisclosed amount. With this acquisition, Katena will expand its production of fine ophthalmic tools and manufacturing facilities. Micro Select Instruments Inc. is full-service surgical instrument manufacturing and repair company. Major players in the hand-held surgical instruments market are Johnson & Johnson, B Braun Melsungen AG, Medtronic, Zimmer Biomet Holdings, KLS MARTIN GROUP, Integra LifeSciences Corporation, Smith & Nephew, Aspen Surgical, CooperSurgical Inc., Thompson Surgical Instruments Inc., Becton Dickinson and Company, Swann-Morton Ltd., Peters Surgical, Huaiyin Medical Instruments CoLtd and CONMED Corporation. North America was the largest region in the hand-held surgical instruments market in 2022. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the hand-held surgical instruments market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa. The countries covered in the hand-held surgical instruments market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK and USA. The hand-held surgical instruments market consists of sales of cannulas, dermatome, and trocars. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products. The global hand held surgical instruments market is segmented - 1) By Product: Forceps, Retractors, Dilators, Graspers, Scalpels, Other Products 2) By Application: Neurosurgery, Cardiovascular, Orthopedic, Plastic And Reconstructive Surgery, Obstetrics And Gynecology, Other Applications 3) By End User: Clinics, Ambulatory Surgical Centers, Other End Users